Total planned funding: $15,951,787
Allocations
Countries/Regions
Central Asia Region | $15,951,787 |
Organizational Types
Own Agency | $15,951,787 |
Program Areas
Management and Operations | $10,244,470 |
Prevention | $2,076,069 |
Governance and Systems | $1,746,371 |
Care | $733,564 |
Testing | $630,417 |
Treatment | $520,896 |
Budget Codes
HVMS: Management and Operations | $10,244,470 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,528,545 |
HLAB: Laboratory Infrastructure | $703,353 |
HVSI: Strategic Information | $642,658 |
HVCT: Testing: HIV Testing and Counseling | $630,417 |
HBHC: Care: Adult Care and Support | $594,003 |
HTXS: Treatment: Adult Treatment | $520,896 |
OHSS: Health Systems Strengthening | $400,360 |
HVOP: Sexual Prevention: Other Sexual Prevention | $366,041 |
HVTB: Care: TB/HIV | $139,561 |
HMBL: Biomedical Prevention: Blood Safety | $131,194 |
HMIN: Biomedical Prevention: Injection Safety | $50,289 |
Top Partner Programs
USG Aggregated Agencies:
$10,174,787
Countries/Regions
Central Asia Region
2012 | $1,121,824 |
2015 | $4,926,674 |
2016 | $4,126,289 |
U.S. Centers for Disease Control and Prevention:
$3,238,500
Countries/Regions
Central Asia Region
2013 | $3,238,500 |
U.S. Agency for International Development:
$2,538,500
Countries/Regions
Central Asia Region
2013 | $2,538,500 |